Neil Flanzraich

Neil William Flanzraich founded Cantex Pharmaceuticals, Inc., where he worked as Chairman & Chief Executive Officer and AgoneX Biopharmaceuticals Inc., where he is working as Chairman.
Mr. Flanzraich also currently works at Alzheon, Inc., as Executive Chairman, Israel American Foundation, Inc., as Chairman, Atlantix Care Corp., as Chairman, Kirax Corp., as Director from 2011, and Neurochem (International) Ltd., as Director from 2009.
Mr. Flanzraich also formerly worked at IVAX LLC, as Vice Chairman & President from 1998 to 2006, North American Vaccine, Inc., as Chairman from 1989 to 2000, Heller Ehrman LLP, as Chairman-Life Sciences Legal Practice Group from 1995 to 1998, CG Seven Holdings, Inc., as Chairman, Continucare Corp., as Independent Director from 2002 to 2011, Equity One, Inc., as Lead Independent Director from 2011 to 2017, RAE Systems, Inc., as Director from 2000 to 2009, ERBA Diagnostics, Inc., as Director from 1998 to 2006, BELLUS Health, Inc., as Independent Director from 2006 to 2012, Chipotle Mexican Grill, Inc., as Lead Independent Director, G City Europe Ltd., as Independent Non-Executive Director, Javelin Pharmaceuticals, Inc., as Director from 2006 to 2010, Outcomes Health Information Solutions LLC, as Director, Syntex Corp., as Senior Vice President & General Counsel from 1981 to 1994, The Cue Ball Group LLC, as Principal, and Syntex (USA), Inc., as Senior Vice President & General Counsel in 1995.
Mr. Flanzraich received his graduate degree from Harvard Law School and undergraduate degree from Harvard College.